Biotech Jason Mast STAT Plus: What to know about a pivotal FDA hearing on Sarepta’s gene therapy for Duchenne
Special Report Jason Mast and Adam Feuerstein STAT Plus: A bellwether moment: Once a distant dream, gene therapy for Duchenne nears historic decision
Biotech Jason Mast and Adam Feuerstein STAT Plus: FDA to convene advisory panel for Sarepta’s gene therapy for Duchenne
Politics Andrew Joseph STAT Plus: Q&A: Califf on obesity drugs, advisory panels, and how threats hurt recruitment at FDA
Pharmalot Ed Silverman STAT Plus: Many pediatric drug study results were never posted to a U.S. government database
Biotech Damian Garde STAT Plus: Weight-loss drug had dramatic effect in adolescents with obesity, study finds
Health tech Casey Ross STAT Plus: Top IQVIA lawyer declines to discuss Experian relationship, but pledges Americans’ medical secrets are safe
Health tech Katie Palmer STAT Plus: A troubling report on Cerner’s VA rollout offers a rare look into the hidden harms of health records
Health tech Tara Bannow STAT Plus: Amazon has big ambitions in primary care. One Medical is just the latest piece of its plan
Health tech Mohana Ravindranath, Casey Ross, and Bob Herman STAT Plus: 5 burning questions about Amazon’s $3.9 billion acquisition of One Medical
Health tech Mohana Ravindranath STAT Plus: Researchers tried to calculate the impact of health tech companies. It sent startups into a tizzy
Health tech Katie Palmer STAT Plus: As health care faces nursing shortages, burned-out nurses are flocking to remote jobs
Opinions+ Jeff Levin-Scherz and Andrey Ostrovsky STAT Plus: 10 tips for vendors seeking to create or expand digital health and virtual health solutions
Health tech Mohana Ravindranath STAT Plus: The pandemic brought an influx of cash for health tech companies — and huge payouts for their execs
Health Jessica Bartlett — Boston Globe STAT Plus: Nursing shortage at Mass. hospitals leads to multimillion-dollar costs
Biotech Matthew Herper and Megan Molteni STAT Plus: Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease
Health tech Katie Palmer STAT Plus: Under new ownership, IBM Watson Health’s core assets get a rebranding
Health tech Mohana Ravindranath and Katie Palmer STAT Plus: The Q3 health tech tracker: 11 key industry events and debates to watch
Biotech Matthew Herper STAT Plus: New analysis of Amarin’s Vascepa resurrects big questions about effectiveness
Health tech Mario Aguilar STAT Plus: Cognito Therapeutics raises $50 million for Alzheimer’s treatment tech
A STAT Investigation Katie Palmer STAT Plus: Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future
Health tech Edward Chen STAT Plus: Smartphone apps promised to help combat the pandemic. How well did they work?
Special Report Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu — The Markup STAT Plus: Facebook is receiving sensitive medical information from hospital websites